SLC7A11 and hepatocellular carcinoma: Our findings also indicate the possibility of using BECN1 mimetics or MCL1 inhibitors to disrupt the BECN1–MCL1 association, leading to inhibition of SLC7A11, which further triggers HCC cell death through ferroptosis.